We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CSL Warned for GMP Issues Following 2010 Untitled Letter
CSL Warned for GMP Issues Following 2010 Untitled Letter
July 5, 2011
Flu vaccine maker CSL Biotherapies has received an FDA warning letter for “significant objectionable conditions” at its Melbourne, Australia, facility following an untitled letter last year for GMP deviations.